Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - OTHER CURRENT LIABILITIES
Other Current Liabilities CRVS - Corvus Pharmaceuticals, Inc.
3.97 M
LAST VALUE
-25.12%
2 YEAR CAGR
-4.62%
5 YEAR CAGR
0.00%
10 YEAR CAGR